ePrivacy and GPDR Cookie Consent by TermsFeed Generator

APIXABAN TEVA

2,5MG TBL FLM 30X1

SÚKL code 0239386
Name of the product APIXABAN TEVA
_MA_MEDICATION_DETAIL_INFO_MED_NAME i APIXABAN TEVA
Supplement 2,5MG TBL FLM 30X1
Strenght 2,5MG
Pharmaceutical form Film-coated tablet
Package 30X1
Route Oral use
Language of the pack Czech
Wrap type
Legal status na lékařský předpis
Active substance APIXABAN (APIXABANUM)
ATC group B01AF02
ATC group name APIXABAN

Marketing authorisation information

Registration Number 16/ 217/19-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 11. 2021
MA Holder Teva B.V., Haarlem
MA Holder country NIZOZEMSKO
Actual MA holder Teva Pharmaceuticals CR, s.r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list